Clinical Characteristics and Outcomes Until 2 Years of Age in Preterm Infants With Typical Chest Imaging Findings of Bronchopulmonary Dysplasia: A Propensity Score Analysis
- PMID: 34497783
- PMCID: PMC8420714
- DOI: 10.3389/fped.2021.712516
Clinical Characteristics and Outcomes Until 2 Years of Age in Preterm Infants With Typical Chest Imaging Findings of Bronchopulmonary Dysplasia: A Propensity Score Analysis
Abstract
Objective: The goal of the current study was to assess the associations of typical chest imaging findings of bronchopulmonary dysplasia (BPD) in preterm infants with clinical characteristics and outcomes until 2 years of age. Method: This retrospective cohort study enrolled 256 preterm infants with BPD who were admitted between 2014 and 2018. A propensity score analysis was used to adjust for confounding factors. The primary outcomes were the severity of BPD, home oxygen therapy (HOT) at discharge and mortality between 28 days after birth and 2 years of age. A multivariate logistic regression analysis was performed to identify related variables of mortality. Results: Seventy-eight patients with typical chest imaging findings were enrolled, of which 50 (64.1%) were first found by CXR, while 28 (35.9%) were first found by CT. In addition, 85.9% (67/78) were discovered before 36 weeks postmenstrual age (PMA) (gestational age [GA] < 32 weeks) or before 56 days after birth (GA > 32 weeks). After propensity score matching, the matched groups consisted of 58 pairs of patients. Those with typical imaging findings had a remarkably higher mortality rate (29.3 vs. 12.1%, p = 0.022, OR 3.021), higher proportion of severe BPD (32.8 vs. 12.1%, p = 0.003, OR 4.669) and higher rate of HOT at discharge (74.1 vs. 46.6%, p = 0.002, OR 3.291) than those without typical imaging findings. The multivariate logistic regression analysis showed that typical imaging findings ≤ 7 days and typical typical imaging findings >7 days were independent risk factors for mortality in preterm infants with BPD (OR 7.794, p = 0.004; OR 4.533, p = 0.001). Conclusions: More attention should be given to chest imaging findings of BPD, especially in the early stage (within 7 days). Early recognition of the development of BPD helps early individualized treatment of BPD. Clinical Trial Registration:www.ClinicalTrials.gov, identifier: NCT04163822.
Keywords: bronchopulmonary dysplasia; clinical characteristics; outcomes; preterm infants; propensity score; typical imaging findings.
Copyright © 2021 Ruan, Wang and Shi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.JAMA Pediatr. 2017 Nov 1;171(11):1081-1089. doi: 10.1001/jamapediatrics.2017.2618. JAMA Pediatr. 2017. PMID: 28973344 Free PMC article. Clinical Trial.
-
Nutritional support during the first week for infants with bronchopulmonary dysplasia and respiratory distress: a multicenter cohort study in China.BMC Pediatr. 2024 Apr 3;24(1):238. doi: 10.1186/s12887-024-04675-5. BMC Pediatr. 2024. PMID: 38570780 Free PMC article.
-
Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.JAMA. 2019 Jan 29;321(4):354-363. doi: 10.1001/jama.2018.21443. JAMA. 2019. PMID: 30694322 Free PMC article. Clinical Trial.
-
Inositol in preterm infants at risk for or having respiratory distress syndrome.Cochrane Database Syst Rev. 2019 Jul 8;7(7):CD000366. doi: 10.1002/14651858.CD000366.pub4. Cochrane Database Syst Rev. 2019. PMID: 31283839 Free PMC article.
-
Association of Chorioamnionitis With Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review, Meta-analysis, and Metaregression.JAMA Netw Open. 2019 Nov 1;2(11):e1914611. doi: 10.1001/jamanetworkopen.2019.14611. JAMA Netw Open. 2019. PMID: 31693123 Free PMC article.
Cited by
-
Inhaled and Systemic Steroids for Bronchopulmonary Dysplasia: Targeting Inflammation and Oxidative Stress.Antioxidants (Basel). 2025 Jul 16;14(7):869. doi: 10.3390/antiox14070869. Antioxidants (Basel). 2025. PMID: 40722975 Free PMC article. Review.
-
Steroid use for established bronchopulmonary dysplasia: study protocol for a systematic review and meta-analysis.BMJ Open. 2022 Jun 15;12(6):e059553. doi: 10.1136/bmjopen-2021-059553. BMJ Open. 2022. PMID: 35705335 Free PMC article.
References
Associated data
LinkOut - more resources
Full Text Sources
Medical